though only a molecule of ketamine called esketamine that’s used in smaller doses is active in Spravato. Ketamine is also sometimes distributed illegally, mostly after being stolen from ...

Esketamine, the S-enantiomer of ketamine, was approved by the FDA in 2019 for the treatment of TRD. It is typically administered intranasally, with an initial dosing regimen of twice-weekly ...

Esketamine, the S isomer of ketamine ... coverage. GM-1020 is a small-molecule orally active antagonist of the N-methyl-d-aspartate (NMDA) receptor that is under development for depression ...

For the first time, the U.S. Food and Drug Administration (FDA) has approved the use of a ketamine-like drug as a stand-alone therapy for adults with treatment-resistant depression (TRD).